Entecavir Maleate

马来酸恩替卡韦

Report date: 2022/12/07 17:16:01

Base Information

Drug NameEntecavir Maleate
Drug Alias Name天丁
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHBV DNA Polymerase inhibitors
TargetsHBV DNA Polymerase
Therapy Area/IndicationsLiver NeoplasmsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date2012/06/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Inactive CompaniesGuangxi Medical University
Active IndicationsHepatitis B
Inactive IndicationsLiver Neoplasms

Other Information

ATC CodeJ05AF10
Related LinksN/A